Member Info for JRjnr

Buying coming back… watch out for more data middle of June…

I think we have had the dip… big buys on Friday… let’s see if the tide is about to turn… bring on the recovery 👊👊

Juho’s interview with Redeye:

https://www.redeye.se/research/1158137/faron-pharmaceuticals-interview-funded-beyond-inflection-points?utm_source=interview

Very disappointed in the placement and certain poor financial strategic decisions… that being said there would be no raise if there was no probability of getting to next stage… the next 6 months faron must rekindle confidence, which must encapsulate clear scientific progress coupled with clear path to transformation… a rebound after placement would begin to restore belief

No… tomorrow I think… what is your latest analysis

Suspect news next week on placement timetable and strike…

Surely news tomorrow on placement price…

£1 - 1.35… I can’t see institutions accepting a placement at less than last one… it’s doesn’t make sense… s

Next week… once placement passed, price will be set, funding risk removed

Not long to go… Shareprice has prices maximum dilution… expecting institutional support at £1.35

Demonstrates that the business continues to move forward and the drop is not a death spiral nor a funding crisis… the placement price will be set in a week or so and the gap caused by a limited number of retail panicked will be closed and share price will stabilise in three figures

No… have to complete EGM first…

Good analysis but it is likely significant holders have been sounded out and a strike price agreed

Look at volume of shares… but guessing at 10%

Not available in volume for institutions as mentioned countless times 💕❤️

Why not?

This is a possibility but the board and current institutions do not want mass dilution as it erodes market cap and undermines flexibility of a further raise… the current institutions equally could take their proportion at £1.35 and sweep up any retail stock not taken.

Bought another 20,000… if tye board we’re panicking we would have seen a RNS… get ready for massive gap close on announcement… as mentioned £1.35 subscription

Cov is not interested in analysis… he knows what’s coming and I’m a little lost by his agenda… he’s got another week or so to buy cheap stock, not sure why he is pressing for Armageddon dilution when it doesn’t aid the company or long standing shareholders… maybe he’s over leveraged and concerned about RNS coming out of nowhere that upends the drop

Or you could make 10 -100 times your money… groundbreaking cancer drug than potentially can be used across cancer spectrum…